Growth Metrics

Gilead Sciences (GILD) Return on Capital Employed (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.00
Dec 31, 2025 -206.00
Sep 30, 2025 546.00
Jun 30, 2025 -18.00
Mar 31, 2025 1,441.00
Dec 31, 2024 177.00
Sep 30, 2024 -385.00
Jun 30, 2024 237.00
Mar 31, 2024 -1,150.00
Dec 31, 2023 -146.00
Sep 30, 2023 -122.00
Jun 30, 2023 60.00
Mar 31, 2023 280.00
Dec 31, 2022 272.00
Sep 30, 2022 -156.00
Jun 30, 2022 35.00
Mar 31, 2022 -505.00
Dec 31, 2021 -256.00
Sep 30, 2021 328.00
Jun 30, 2021 919.00
Mar 31, 2021 18.00
Dec 31, 2020 251.00
Sep 30, 2020 717.00
Jun 30, 2020 -1,063.00
Mar 31, 2020 13.00
Dec 31, 2019 6.00
Sep 30, 2019 -720.00
Jun 30, 2019 22.00
Mar 31, 2019 2.00
Dec 31, 2018 123.00
Sep 30, 2018 -225.00
Jun 30, 2018 -268.00
Mar 31, 2018 -334.00
Dec 31, 2017 -763.00
Sep 30, 2017 -258.00
Jun 30, 2017 -153.00
Mar 31, 2017 -292.00
Dec 31, 2016 -843.00
Sep 30, 2016 -758.00
Jun 30, 2016 -223.00
Mar 31, 2016 155.00
Dec 31, 2015 -506.00
Sep 30, 2015 -423.00
Jun 30, 2015 251.00
Mar 31, 2015 180.00
Dec 31, 2014 811.00
Sep 30, 2014 876.00
Jun 30, 2014 816.00
Mar 31, 2014 563.00
Dec 31, 2013 295.00
Sep 30, 2013 35.00
Jun 30, 2013 48.00
Mar 31, 2013 51.00
Dec 31, 2012 11.00
Sep 30, 2012 -81.00
Jun 30, 2012 -106.00
Mar 31, 2012 -488.00
Dec 31, 2011 -550.00
Sep 30, 2011 53.00
Jun 30, 2011 -350.00
Mar 31, 2011 -484.00
Mar 31, 2010 -68.00
Dec 31, 2009 52.00